Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sionna Therapeutics
Biotech
Sionna goes public in $135M IPO, Aardvark plots $103M listing
Sionna is joining the Nasdaq with an upsized offering, while obesity biotech Aardvark unveiled plans for a nine-figure IPO of its own.
James Waldron
Feb 7, 2025 4:40am
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Feb 3, 2025 9:59am
Odyssey, Sionna join band of biotechs braving the IPO waters
Jan 21, 2025 5:27am
TPG tops up funds to $580M for investments across life sciences
Aug 6, 2024 11:45am
Sionna salvages AbbVie assets for assault on cystic fibrosis
Jul 16, 2024 10:00am
Sionna adds $182M to extend pipeline, cash runway through 2026
Mar 6, 2024 8:00am
